Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound anti-T2DM and vascular lesion preparation for treating diabetes great blood vessel complication and preparation method and usage method thereof

A technology for vascular lesions and compound preparations, applied in the field of medicine, can solve the problems of no obvious curative effect, etc., and achieve the effects of good curative effect, no recurrence, and quick effect.

Inactive Publication Date: 2017-01-04
刘江月
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many drugs have shown good preventive and therapeutic effects in animal experiments, but have no obvious curative effect in clinical practice

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] For the convenience of explanation, a compound preparation for treating diabetic macrovascular complications, anti-T2DM and vascular lesions, its preparation method and its use method will be described in detail below.

[0032] A compound preparation for treating diabetic macrovascular complications, anti-T2DM and vascular lesions, comprising 10-12 parts of angelica, 3-5 parts of chuanxiong, 18-30 parts of astragalus, 7-14 parts of kudzu root and 12 parts of earthworm by weight -18 parts, mulberry branch 8-10 parts, Polygonatum 9-10 parts, Melonium root 15-30 parts, Ophiopogon japonicus 10-18 parts, Schisandra 10-11 parts, Gurixiang 30-52 parts, Fangji 2 -3 parts, 0.05-0.07 parts of arsenic, 6-11 parts of Dong Lingcao, 10-11 parts of Polygonum cuspidatum root, 3-5 parts of vine pear root, 6-7 parts of salicylum root, 11-12 parts of Codonopsis pilosula, 2- 4 parts, 11-12 parts of poria cocos, 3-7 parts of hawthorn meat, 1-3 parts of licorice, 17-23 parts of Brucea javani...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a compound anti-T2DM and vascular lesion preparation for treating diabetes great blood vessel complication. The compound preparation is prepared from, by weight, 0.05-0.07 part of white arsenic, 15-18 parts of tender willows, 19-21 parts of bitter gourds, 11-18 parts of five-leaf gynostemma herb, 12-15 parts of spinach roots, 12-16 parts of mung bean shells, 12-13 parts of bergamot, 2-9 parts of acanthopanax obovatus hoo, 2-4 parts of kiwi fruit roots and 3-8 parts of toad venom and is prepared through decoction with water. The preparation has is quick in effect, good in curative effect, free of toxic and side effects, non-poisonous, harmless and strong in curing effect and makes the complication not relapse.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine preparation for treating diabetic macrovascular complications, a preparation method and a use method. Background technique [0002] Diabetic macroangiopathy refers to atherosclerosis in the aorta, coronary arteries, cerebral basilar arteries, renal arteries, and peripheral arteries. Compared with the non-diabetic population, the prevalence of atherosclerosis in the diabetic population is higher, the age of onset is younger, and the disease progression is faster. The condition is severe and the fatality rate is high. About 70% to 80% of diabetic patients die from diabetic macrovascular disease. Among them, diabetes combined with coronary heart disease, myocardial infarction, and acute cerebrovascular disease are the main causes of death in diabetes. [0003] In recent years, due to many factors such as the improvement of living standards, changes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/76A61K36/8969A61K36/8968A61K36/8994A61P3/10A61P9/10A61K33/36A61K35/65A61K35/62A61K35/646A61K35/39A61K35/413A61K31/704A61K31/4965
CPCA61K33/36A61K31/4965A61K31/704A61K35/39A61K35/413A61K35/62A61K35/646A61K35/65A61K36/07A61K36/076A61K36/185A61K36/23A61K36/232A61K36/236A61K36/254A61K36/284A61K36/344A61K36/42A61K36/424A61K36/428A61K36/48A61K36/481A61K36/484A61K36/488A61K36/52A61K36/53A61K36/57A61K36/59A61K36/605A61K36/70A61K36/704A61K36/73A61K36/734A61K36/75A61K36/752A61K36/76A61K36/79A61K36/815A61K36/8945A61K36/8962A61K36/8968A61K36/8969A61K36/899A61K36/8994A61K2236/331A61K2236/333A61K2236/51A61K2300/00
Inventor 刘江月
Owner 刘江月
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products